Trethera Phase 1 Solid Tumors Trial Dose Escalates To Fourth Cohort After Safety Review Committee Determines Primary Trial Endpoint Achieved
LOS ANGELES, June 01, 2022 (GLOBE NEWSWIRE) — Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical…
AISIX Solutions Inc. and Re: Drying Equipment Inc. Announce Update to Proposed Reverse Takeover Transaction
Arkansas Governor Sarah Huckabee Sanders Visits CoorsTek Benton Facility
ImagineAR Announces Agreement to Acquire s3iai Inc.
ANK Constructions & Interiors Launches No-Cost Snagging Inspections for Dubai Property Owners
NamSys Announces Normal Course Issuer Bid